Uveitis remains one of the leading causes of preventable vision loss worldwide, accounting for nearly 10–15% of blindness cases in developed countries. Its complex and multifactorial nature poses significant diagnostic and therapeutic challenges, demanding prompt detection and targeted intervention to preserve sight. In recent years, advances in immunomodulatory therapies, biologics, and precision diagnostics have opened new possibilities for controlling inflammation and preventing irreversible ocular damage. As research accelerates, clinicians and researchers are moving closer to more effective, personalized strategies that can address both the underlying causes and ...
